[ Skip to main content ]

News and reports

Article

Q&A: I’m Lotta. I’m an alcoholic.

1 Aug 2014

Lotta Dann, the journalist wife of TVNZ political editor Corin Dann and a mother of three, has outed herself as a recovering alcoholic and released a book, Mrs D is Going Without, which has quickly become a bestseller.

Article

Mythbusters: Substance and substantiation

1 Aug 2014

Tobacco plain packaging laws are an experiment that hasn’t worked. Tobacco companies claim the new law has led to a booming black market for cheap cigarettes instead of stamping out smoking.

Article

Viewpoints: So should naloxone become more accessible in New Zealand?

1 Aug 2014

In the US, opiates cause thousands of overdose deaths each year. Making naloxone more readily available here would widen the safety net for overdose victims.

Article

Decriminalise cannabis, decriminalise Māori?

1 Aug 2014

That Māori are more often criminalised for cannabis use is often used as another good argument for decriminalisation. Hirini Kaa argues things are more complex than that.

Article

Guest editorial: Towards global drug policy pathways that work

1 Aug 2014

The Global Commission on Drugs proposes a new drug control regime for the 21st century. The experience of what regulation means in practice is informing policy, as Steve Rolles explains

Article

Face Trashed

1 Aug 2014

Alcohol marketing on social media is cheap, successful and legal. But researchers say New Zealand should be attempting to control marketers’ sophisticated digital strategies.

Article

Doing LAPs

1 Aug 2014

With few Local Alcohol Plans (LAPs) in place, communities are forced into being reactive when faced with new applications for liquor licences.

Article

Shulgin was known to many as the “Godfather of ecstasy”

1 Aug 2014

Alexander “Sasha” Shulgin was born on 17 June 1925 and died, aged 88, at home in California on 2 June 2014.

Media release
May 10
2014

Medical cannabis report disappointing

10 May 2014

A report on medical cannabis published yesterday by the Health Select Committee is a disappointing once-over glance at a medicine that is of increasing importance globally, the New Zealand Drug Foundation said.